Gum Arabic

What is Gum Arabic?

Before war broke out in April 2023, Sudan supplied an estimated 70 to 80 percent of the world's crude gum arabic exports, according to the UN human rights office. The same powder, relabeled "acacia fiber," is now sold in supplement aisles as a gentle prebiotic, and most of it still traces back to a belt of dry savanna running through Kordofan, Darfur, Blue Nile, White Nile, Sennar and Gedaref.

Gum arabic is the dried gummy exudate that seeps from cuts in the stems and branches of two African trees. The Joint FAO/WHO Expert Committee on Food Additives (JECFA) defines it as coming from Acacia senegal (L.) Willdenow or Acacia seyal, and the US Pharmacopeia's older National Formulary monograph allowed A. senegal "or related African Acacia species." Collectors tap the trees, let the sap harden into tear-shaped lumps, and sell the lumps to traders who sort, clean and export them. French and German firms are the largest European buyers of the raw gum, which processors dissolve, filter and spray-dry into the fine white powder found in food plants and fiber jars. The UN office estimates that the trade supports about five million people. International buyers imported close to 200,000 tonnes in 2024, a market worth nearly $300 million, according to a January 2026 Al Jazeera report.

Industry uses it as an emulsifier and stabilizer in soft drinks, candy and tablet coatings; supplement makers sell it as a soluble fiber; and in Sudan and neighboring countries it is a folk remedy for kidney failure.

Common Names

• Gum arabic, acacia gum, gum acacia, acacia, acacia fiber, organic acacia powder

• E 414 (European Union food additive number) and INS 414 (Codex)

• Hashab: the Sudanese trade name for the premium gum from A. senegal

• Senegalia senegal: the current botanical name for Acacia senegal. In July 2005 the International Botanical Congress in Vienna voted to keep the name Acacia for the roughly 1,000 mainly Australian species, a decision upheld in Melbourne in July 2011, which left most African species to be renamed into Senegalia or Vachellia

• Vachellia seyal: the current name for Acacia seyal, the second permitted source, whose gum is cheaper and emulsifies less well

• Not to be confused with Acacia rigidula (blackbrush acacia), a Texas shrub sold in stimulant weight-loss products (see Quality, Testing & Adulteration)

Primary Active Compounds

• A highly branched arabinogalactan-protein complex. Fractionation work by Renard, Sanchez and colleagues in France puts the main arabinogalactan (strictly, arabinogalactan-peptide) fraction at about 88 percent of A. senegal gum (Biophysical Journal 2007); an arabinogalactan-protein fraction of about 10 percent and a glycoprotein fraction of 1 to 2 percent make up the rest.

• Sugars dominated by galactose and arabinose, with rhamnose and charged uronic acids (17 percent uronic acid in one commercial sample; Grein and colleagues, Carbohydrate Polymers 2012).

• Mineral counterions. The gum is a salt of calcium, magnesium and potassium; Tübingen physiologists found its solutions "particularly high" in all three (Nasir and colleagues, Journal of Renal Nutrition 2008). Swanson's organic acacia powder label lists 60 mg of calcium per 5 g scoop as a typical analysis.

• Protein. A. senegal gum carries more protein than A. seyal gum (Alqahtani and Al-Hariri, International Journal of Molecular Sciences 2026), and the protein portion drives both its emulsifying power and, in sensitized workers, its allergenicity.

• Soluble fiber. Nexira guarantees a minimum of 90 percent soluble fiber on a dry basis in its Fibregum ingredient.

Key Note

Gum arabic behaves unlike most soluble fibers. It dissolves to about 500 g per liter, and a 10 g dose stirred into juice stays thin rather than turning to gel. That is why a trial can hide 20 or 40 g of it in a glass of orange juice. The two permitted species can be told apart in the laboratory: JECFA's identity test notes that A. senegal solutions rotate polarized light to the left and A. seyal solutions to the right.

Gum arabic is a food additive with a 2021 American fiber designation, a modest prebiotic record at around 10 g a day, and a supply chain that runs through a war zone.

Scan any Gum Arabic product in seconds with the free NutrientWise app: App Store · Google Play

Primary Functions & Benefits

Gum arabic has three human effects with controlled trial support, and its US fiber designation rests on the weakest of them.

What the FDA accepted, and why it took two tries

FDA's 2016 Nutrition Facts rule let an isolated carbohydrate count as "dietary fiber" only if it showed a physiological benefit in people, such as lower blood glucose, cholesterol or blood pressure, more frequent bowel movements, better mineral absorption or lower energy intake. Gum arabic was left off FDA's 2018 list. The first petition, dated April 19, 2019, cited energy intake, blood glucose and bowel function. The second, from Nexira, Alland & Robert and Importers Service Corporation in late December 2020, kept only postprandial glucose and insulin; according to Food Business News it cited 10 public studies, and FDA drew its conclusions from 5. FDA's December 2021 letter found the evidence supports that gum acacia "can help reduce blood glucose and insulin levels" when eaten with a carbohydrate-containing meal. The author found no final rule completing that change as of this issue, so the American fiber status of acacia is a stated enforcement policy, not yet a line in the regulation.

Beyond the null area-under-the-curve result described above, the Minnesota crossover (24 men, 24 women, treatments a week apart) found no change from baseline glucose at any time point for either dose. Measured glucose at 30 minutes was lower with 20 g (136.7 mg/dL against 144.2 mg/dL on control, p = 0.013); 40 g only trended (p = 0.055). The authors wrote that acacia "does not produce a predictable glycemic response in healthy humans." They cited an earlier crossover by Sharma in 12 healthy men that did find a lower glucose area after 20 g. Nexira's own trial, run by the Berlin contract research firm Analyze & Realize, was unpublished when the petition was submitted; Nexira describes it as a crossover in 35 adults testing single doses of 20 and 40 g, with significant reductions in postprandial glucose and insulin at both doses and no difference between them, later published in Food and Nutrition Sciences (2022).

A bifidobacteria shift at about 10 g a day

Calame and colleagues at Kerry's nutrition center in the Netherlands gave healthy volunteers 5, 10, 20 or 40 g a day of Kerry's EmulGold gum arabic in 250 mL of water for 4 weeks, against water and against 10 g of inulin (British Journal of Nutrition 2008). Of 51 who started, 48 finished, spread across six parallel groups, an average of eight per group (the paper does not give group sizes). At 10 g, bifidobacteria in stool rose about 40-fold more than with water and about 10-fold more than with inulin, and lactobacilli about 6-fold more than water. The higher doses did not do better: lactobacilli fell back at 20 g and bacteroides at 40 g. The authors put the optimal dose at about 10 g. With groups this small, and authors drawn from the gum's supplier and a Dutch contract research firm, this is an encouraging signal, not a settled dose-response curve.

More frequent bowel movements in constipation-predominant IBS

The best-designed trial of acacia fiber is the NUTRIC study from Wageningen University (JanssenDuijghuijsen and colleagues, European Journal of Nutrition 2024). After a 4-week run-in, 180 adults meeting the Rome IV criteria for IBS with constipation were randomized to Nexira's Inavea Pure Acacia (5 g a day for 5 days, then 10 g a day in two sachets), a probiotic, or 10 g of maltodextrin, each mixed into orange juice, for 4 weeks. Among the 55 acacia and 57 placebo participants analyzed per protocol, stool frequency rose by 1.3 stools a week on acacia against 0.4 on placebo (p = 0.02), a margin of 0.9. The authors judged the 1.3 gain clinically meaningful against the FDA's benchmark of more than one extra stool a week in IBS with constipation, though that benchmark was applied to the within-group change, not the margin over placebo. Stool consistency, stool mass, IBS symptom severity scores and quality of life did not differ from placebo. One of the seven authors was a Nexira employee, and the authors reported analyses for the per-protocol population only.

Forms & Standardization

Gum arabic is not an extract, so it has no extract ratio and no marker-compound percentage. What varies between products is species, grade, processing and how much of the powder counts as soluble fiber. None of that changes absorption, because the gum is not absorbed intact (EFSA 2017).

Raw gum ("tears" and kibbled gum)

The traded commodity: hardened lumps hand-collected from tapped trees, graded by color and cleanliness, sometimes broken into kibbles. Sudanese hashab from A. senegal is the premium grade. Raw gum is not sold to consumers as a supplement in the products reviewed for this issue; it is the input that European processors dissolve, filter and dry.

Spray-dried food grade (E 414)

The form in soft drinks, candy and tablets. JECFA's specification (prepared at its 51st meeting in 1998 and republished in 1999) allows no more than 10 percent loss on drying for spray-dried gum and 15 percent for granular gum, no more than 4 percent total ash, 0.5 percent acid-insoluble ash and 1 percent acid-insoluble matter, and no more than 2 mg/kg of lead. It requires Salmonella to be absent per test and E. coli absent in 1 g, and it screens for substitution with simple chemical tests: iodine should produce no blue or red color (no added starch or dextrin) and ferric chloride no black precipitate (no tannin-bearing gums). Four percent ash means up to 40 mg of mineral residue per gram, the fraction that carries the gum's calcium, magnesium and potassium.

Branded fiber ingredients

• Fibregum (Nexira, Rouen): sold to manufacturers with a guaranteed minimum of 90 percent soluble fiber on a dry basis, made in France, with specific grades certified Fair for Life. Nexira's page shows a FODMAP Friendly logo and lists no recommended daily intake.

• Inavea Pure Acacia (Nexira): the product given in the Wageningen IBS trial.

• EmulGold (Kerry): the spray-dried gum used in Calame's 2008 prebiotic trial.

Retail acacia fiber powders

• NOW Foods Acacia Fiber, Organic Powder (12 oz): 1 level tablespoon, about 6.5 g of organic acacia gum, supplying 6 g of dietary fiber (all soluble), about 52 servings. Species: Acacia senegal and Acacia seyal. Directions: 1 tablespoon daily in at least 8 oz of water or juice, starting at 1 teaspoon if sensitive to fiber. Labeled for adults only.

• Heather's Tummy Fiber, Organic Acacia Senegal: sold as 16 oz pouches and as travel stick packs of 2.5 g, which a retailer lists as 2.0 g of soluble fiber per packet. The brand's selling point is species: it describes itself as "100% Acacia senegal, never low grade Acacia seyal," and is marketed for relief of irritable bowel syndrome symptoms.

• Swanson Certified Organic Acacia Fiber Powder: one 5 g scoop of A. senegal gum, up to three times a day, with 60 mg of naturally occurring calcium per scoop listed as a typical analysis.

Senegal versus seyal

A. seyal gum has less protein and weaker emulsifying power, which is why the food industry values it less (Bi and colleagues, Food Chemistry 2016). For fiber purposes, no human trial found for this issue compared the two species head to head, so "100 percent senegal" is a statement about grade and provenance, not a demonstrated health difference. The trials do not always say which species they used. Calame's paper describes gum arabic as coming from A. senegal or A. seyal without saying which supplied its EmulGold; the Wageningen and Minnesota papers name the Nexira product but not its species; the Khartoum trials of Babiker and Kaddam name Acacia senegal.

Products that only share the name

On a weight-loss or stimulant label, "acacia" can mean Acacia rigidula leaf extract, which is not gum arabic and is covered in Quality, Testing & Adulteration.

Food Sources

Gum arabic is not a food anyone eats on purpose. It reaches the diet as an additive, and the amounts are capped by regulation rather than measured on labels.

Where it is used, and the US ceilings

FDA affirmed acacia as generally recognized as safe under 21 CFR 184.1330, which sets maximum levels as served: 2.0 percent in beverages and beverage bases, 5.6 percent in chewing gum, 12.4 percent in confections and frostings, 46.5 percent in hard candy and cough drops, 85.0 percent in soft candy, 8.3 percent in nuts and nut products, 6.0 percent in frozen confections, 4.0 percent in snack foods, 2.5 percent in gelatins and puddings, and 1.0 percent in all other foods. A separate rule published February 17, 2005 (21 CFR 172.780), granted on a petition from Kerry, Inc., allows up to 20 percent in alcoholic beverages, a use the petition described as creamers for alcoholic drinks. These are ceilings. Actual content is rarely printed, and a label that lists "gum arabic" or "acacia gum" between two other minor ingredients gives no gram figure.

How much people actually get

In that 2005 rule FDA estimated existing US intake of acacia at about 2.5 g per person per day, and calculated that the alcoholic beverage use would add no more than 0.75 g a day among people who drink those products. That background intake is a quarter of the 10 g used in the Calame and Wageningen trials. In the EU, E 414 is permitted in foods including unflavored fermented milk products, cheeses and foods for infants and young children; market data reported alongside EFSA's review found it labeled on snacks, breakfast cereals, alcoholic drinks and nectars. EFSA concluded in 2017 that its use as an additive raised no safety concern for the general population.

Is diet sufficient?

There is no gum arabic requirement to meet. Additive intake will not reach the 10 g a day used in the trials, and a general fiber goal can be met from whole foods without any gum.

Who Should Take Gum Arabic

The adults for whom a trial of acacia fiber is defensible are a short list, and none of them is defined by a blood sugar or kidney diagnosis.

Adults with constipation-predominant IBS who want more frequent bowel movements

The Wageningen trial supports 10 g a day for this group, with 0.9 more stools a week than placebo and no worsening of bloating, pain or flatulence scores against maltodextrin. It did not improve overall IBS symptom severity or stool consistency, so it is a frequency aid, not an IBS treatment.

Adults who need more soluble fiber and tolerate other fibers poorly

Tolerance is acacia's strongest selling point: in the Wageningen trial, gastrointestinal complaints on 10 g a day did not differ from placebo, and the higher-dose tolerance data are under Potential Negatives.

Who should be steered elsewhere

• Anyone hoping to treat high blood sugar. The FDA-accepted effect is acute and meal-specific, and people with diabetes need their prescribed treatment.

• Anyone with kidney disease considering it as a kidney treatment (see Critical Safety Point).

• Anyone hoping for weight loss: the BMI changes in trials were fractions of a unit at 30 g a day.

Who Should AVOID or Use Caution

Contraindications

• Known sensitization to gum arabic, including from work. Gum arabic dust is a documented occupational allergen. Viinanen and colleagues at Turku University Hospital diagnosed occupational asthma caused by gum arabic in 4 of 11 candy factory workers referred for respiratory and skin symptoms; two also had contact urticaria, one had rhinitis, and one had oral symptoms, later angioedema, from eating products containing gum arabic (Journal of Allergy 2011). Sander and colleagues in Bochum confirmed asthma by bronchial challenge in a pharmaceutical worker exposed to gum arabic dust in a tablet coating plant (International Archives of Allergy and Immunology 2006). Earlier outbreaks of asthma and rhinitis in printing works were reported by Hinaut and colleagues in a French thoracic medicine journal in 1961 and by Cuthbert in the Annals of Occupational Hygiene in 1973. A worker who wheezes around the powder should not drink it.

• Use in place of dialysis or prescribed kidney care. See Critical Safety Point.

• Children, unless a clinician directs it. NOW Foods labels its powder for adults only, and the pediatric data found for this issue come from uncontrolled studies: a Sudanese sickle cell study (see Special Considerations) and the Baghdad kidney series (see Critical Safety Point).

Use Caution

• Chronic kidney disease at any stage, especially with a potassium, calcium or phosphate prescription. The gum is a calcium, magnesium and potassium salt, no acacia label reviewed for this issue states its potassium, and the kidney trials under Benefits measured serum calcium rising in dialysis patients taking 50 g a day. No trial established a safe self-directed amount for anyone with kidney disease; any use belongs in the hands of the nephrologist or renal dietitian.

• Diabetes treated with glucose-lowering drugs. In Babiker's 2018 trial all 91 participants were on hypoglycemic agents and took 30 g a day for 3 months; the abstract reports no hypoglycemia data either way. Check glucose more often when starting.

• Amoxicillin and other oral medicines taken at the same time (see Interactions).

• Pregnancy and breastfeeding. Food-additive amounts are not a concern, but no trial of supplement-level doses in pregnancy was found.

• Pollen-allergic people with positive allergy tests. In Sander's control group, 7 of 119 people had a positive skin prick test and 5 of 43 had specific IgE to gum arabic, mostly directed at carbohydrate structures that the authors thought less likely to cause allergy than the protein chains, although an earlier case report (Fötisch and colleagues, Allergy 1998) attributed one patient's gum arabic allergy to carbohydrate structures. A positive test alone is not proof of allergy, but it is a reason to start with a small dose.

Critical Safety Point

Gum arabic has a reputation in Sudan and neighboring countries as a treatment for kidney failure, and that reputation has a published case series that should alarm anyone tempted to act on it. Al Mosawi, a pediatrician in Baghdad, reported in Clinical and Experimental Nephrology (2009) on six patients with end-stage kidney disease enrolled in December 2001. Three received conservative measures plus acacia gum instead of dialysis. One complied for 10 days and died after 6 months on peritoneal dialysis. Two completed a year; one of them then stopped the gum and died within a month despite intermittent peritoneal dialysis, and one girl remained off dialysis for 6 years. The three patients managed with intermittent peritoneal dialysis all died within 6 months. Two of six survived the first year, there was no randomization, and the account rests on one surviving patient. A later Saudi trial did not even reproduce the drop in urea (see Benefits). End-stage kidney failure without dialysis or a transplant is fatal, and nothing in the gum arabic record changes that.

Recommended Dosages

No regulator sets a dose for gum arabic as a supplement. JECFA allocated an acceptable daily intake "not specified" at its 35th meeting in 1989, and EFSA concluded in 2017 that no numerical limit was needed, which are statements about additive safety, not about benefit. The figures below are label directions and the doses tested in trials of healthy adults or adults with constipation-predominant IBS.

What the labels say

• NOW Foods Acacia Fiber, Organic Powder: 1 level tablespoon (6.5 g) daily, starting at 1 teaspoon if sensitive to fiber.

• Swanson Organic Acacia Fiber: one 5 g scoop up to three times a day (up to 15 g).

• Heather's Tummy Fiber travel packs: 2.5 g each, about 2.0 g of soluble fiber.

Constipation-predominant IBS, adults

The Wageningen regimen: 5 g a day for the first 5 days, then 10 g a day as two 5 g doses, for 4 weeks. That is about one and a half NOW tablespoons, two Swanson scoops or four Heather's packets a day.

Prebiotic (bifidobacteria) effect, healthy adults

About 10 g a day for 4 weeks (Calame 2008). The 20 and 40 g arms did not add to the effect.

The tolerance ceiling, not a target

EFSA accepted that up to 30 g a day for up to 18 days was well tolerated in adults, with flatulence in some. Higher-dose regimens from glucose, weight, sickle cell and kidney trials (20 to 50 g a day) appear under Special Considerations, framed as research history rather than instructions.

Duration

The controlled human exposures located lasted from a single meal (glucose tests) to 3 months (diabetes, sickle cell and dialysis trials). None found ran longer. Lifetime exposure at additive levels is supported by animal data, including a 103-week rodent study at up to 5 percent of the diet that showed no carcinogenicity (US National Toxicology Program, reviewed by EFSA in 2017).

Timing & Administration

Build up over a week. Wageningen started at 5 g a day for 5 days specifically to avoid the gastrointestinal complaints of a sudden fiber increase, and NOW's label starts sensitive users at 1 teaspoon.

Split the dose. The IBS trial gave one 5 g sachet in the morning and one in the evening.

Dissolve it fully in liquid. Calame used 250 mL of water; Wageningen and Minnesota used orange juice. NOW directs at least 8 oz per tablespoon.

Take it with the meal if the goal is glucose. FDA's accepted effect applies when acacia is eaten with a carbohydrate-containing meal; taken alone, there is nothing for it to blunt.

Keep it apart from amoxicillin. No study has defined a safe interval (see Interactions).

Mix without raising dust if you have asthma. The documented sensitization route is inhaled powder. Pour gently, or use pre-measured packets.

Timeline of Effects

Minutes. In Minnesota, 40 g increased fullness at 15 minutes and again at 240 minutes; the only glucose difference was a dip at 30 minutes with 20 g.

Days. Side effects cluster in the first week. In Babiker's 6-week trial of 30 g a day, viscous mouth feel, early-morning nausea, mild diarrhea and bloating were reported only in week one; in Kaddam's sickle cell study, 37 percent reported minor side effects that resolved within a week.

Two to four weeks. Calame sampled stool at 1, 2 and 4 weeks and reported the significant bifidobacteria and lactobacilli differences at 4 weeks. The Wageningen stool frequency effect was measured over a 4-week intervention after a 4-week run-in.

Six weeks to three months. The body composition, diabetes and sickle cell trials measured outcomes at 6 weeks to 3 months.

A fair trial. For stool frequency, 4 weeks at 10 g a day. If bowel habits have not changed by then, the trial evidence offers no reason to expect they will at 8 weeks, and a higher dose has not been shown to work better.

Benefits of Taking Gum Arabic

Beyond the three effects in Primary Functions, gum arabic has a cluster of trials from Khartoum and the Gulf on body weight, diabetes markers, kidney disease and sickle cell anemia. Most used 30 to 50 g a day, about 5 to 8 times the single 6.5 g tablespoon NOW Foods directs.

Body fat in healthy women

In a double-blind trial at the University of Khartoum, Babiker and colleagues reported that 120 healthy women completed 6 weeks of either 30 g a day of gum arabic (60 women) or 1 g a day of pectin as placebo (60 women) (Nutrition Journal 2012). The abstract reports the result as a pre-to-post change within the gum group: BMI fell by 0.32 (95 percent CI 0.17 to 0.47) and skinfold-estimated body fat by 2.18 percentage points (95 percent CI 1.54 to 2.83). It does not report a between-group comparison, which is the number a randomized trial exists to provide, and a 1 g pectin "placebo" is not matched in volume or taste to 30 g of gum.

Type 2 diabetes markers

The same group randomized 91 people with type 2 diabetes (73 women, 18 men, mean age 50) on hypoglycemic drugs to 30 g of gum arabic or 5 g of placebo daily for 3 months (Lipids in Health and Disease 2018). In the gum group BMI fell 2 percent, the visceral adiposity index 23.7 percent and body adiposity index 3.9 percent, with no change in waist circumference or waist-to-hip ratio. Systolic blood pressure fell 7.6 percent on gum and 2.7 percent on placebo from baseline; diastolic pressure did not change in either group.

The pooled picture

Jumaa and colleagues pooled 6 randomized trials with 476 participants (Journal of Diabetes and Metabolic Disorders 2026). Gum arabic lowered BMI by 0.38 units (95 percent CI 0.29 to 0.47), weight by 1.00 kg (95 percent CI 0.41 to 1.59) and fasting blood glucose by 29.76 mg/dL (95 percent CI 7.65 to 51.88). The glucose estimate came with heterogeneity of 93 percent, meaning the trials disagreed too much to trust a single pooled number, and the authors asked for the results to be "taken cautiously" given the few trials and short follow-up.

Cholesterol

Ross, Eastwood and colleagues gave men gum arabic for 3 weeks (American Journal of Clinical Nutrition 1983). Serum cholesterol fell, while glucose tolerance and stool weight barely changed and fecal bile acids did not rise. EFSA's 2017 summary of the human data likewise lists a decrease in serum cholesterol among the minor effects. No modern lipid trial of acacia fiber at label doses was found for this issue.

Chronic kidney disease: lower urea, unproven kidney benefit

• Bliss and colleagues at the University of Pennsylvania gave 16 people with chronic renal failure on a low-protein diet 50 g a day of gum arabic or 1 g of pectin in a single-blind crossover (American Journal of Clinical Nutrition 1996). Fecal bacterial mass and fecal nitrogen rose and serum urea nitrogen fell during the gum phase; overall nitrogen balance did not change.

• Ali and colleagues at the University of Gezira randomized 36 hemodialysis patients in central Sudan, all on a low-protein diet, into three groups (12 with 50 g a day of gum, 14 with gum plus iron and folic acid, 10 with iron and folic acid alone) and also gave 50 g a day to 10 healthy volunteers, for 3 months (Natural Product Research 2008). Pre-dialysis urea fell 31.2 and 44.18 percent in the two gum groups, phosphorus fell 22.54 and 17.69 percent, and serum calcium rose 12.64 and 15.75 percent.

• Elamin and colleagues at King Fahad Specialist Hospital in Dammam randomized 36 patients to 10, 20 or 40 g a day for 4 weeks (International Journal of Nephrology 2017). Thirty completed. "In contrast to previous observations," urea and creatinine did not change. C-reactive protein fell from 3.5 to 2.8 (units as reported in the abstract), including in the 10 g group, and serum sodium dropped from 138 to 136 mmol/L.

The explanation supported by Bliss's fecal nitrogen data is that lower urea reflects nitrogen diverted into colonic bacteria and out in stool, not restored kidney filtration. None of the three trials measured the outcomes that matter in kidney disease: time to dialysis, hospitalization or death.

Sickle cell anemia

Kaddam and colleagues gave 30 g a day for 12 weeks to 47 Sudanese patients aged 5 to 42 with hemoglobin SS (BMC Hematology 2015). Fetal hemoglobin rose (95 percent CI for the change 0.43 to 1.02), as did mean cell volume and hematocrit. The rationale was that colonic fermentation raises blood butyrate, which induces fetal hemoglobin, but the abstract lists no butyrate measurement, and the study had no control group. A 2020 retrospective analysis of stored samples from the same cohort reported lower C-reactive protein after 12 weeks.

What gum arabic has not been shown to do

No trial found for this issue tested it against an outcome a patient feels or a doctor counts as an event: fewer diabetes complications, delayed dialysis, fewer sickle cell crises, or sustained weight loss beyond 3 months. The Sudanese trials were small, mostly single-center, and used doses that few retail labels approach.

Potential Negatives & Side Effects

Gas and bloating, dose-related and early

The common effects are flatulence, bloating and gut rumbling. EFSA considered flatulence at up to 30 g a day for 18 days "undesirable but not adverse." In Minnesota, 40 g in one sitting produced significantly more bloating, flatulence and rumbling than control, though scores stayed low; the 20 g dose was not reported as different. Babiker's first-week complaints are listed under Timeline of Effects.

Allergy

Inhaled dust is the established route (see Contraindications). EFSA's 2017 panel found no case reports of allergic reaction after oral exposure, but reports exist. A patient in Nancy, France, had two anaphylactic reactions with cardiac arrest after drinking coffee, with sensitization shown to both coffee and the gum arabic coating the roasted beans; beta-blocker eye drops were judged to have made the reactions worse (Moneret-Vautrin and colleagues, Revue de Médecine Interne 1993). In Viinanen's Finnish series, one sensitized candy worker had oral symptoms from eating gum arabic products and later angioedema from such foods, which persisted after her workplace exposure ended. Oral allergy appears rare, and most people at risk were first sensitized through dust. FDA's 2005 rule described the evidence of allergic potential from eating acacia as very weak while acknowledging hypersensitivity in workers exposed to acacia dust.

Minerals that the label does not state

At 50 g a day, the dialysis patients in Ali's study had serum calcium rise by up to 15.75 percent, and patients in the Saudi trial saw sodium fall by 2 mmol/L. For most people this is trivial. For someone on a potassium or calcium restriction, a powder that is a calcium, magnesium and potassium salt with no potassium figure on the label is a reason to ask the dietitian first.

Reduced drug absorption

Amoxicillin is the documented case (see Interactions).

The wrong acacia

The most serious harm associated with the word "acacia" on a supplement label has nothing to do with gum arabic: the BMPEA stimulant found in Acacia rigidula products, covered in Quality, Testing & Adulteration.

Deficiency Symptoms

What gum arabic addresses

Nothing that can be deficient. No state of gum arabic deficiency exists. The relevant shortfall is total fiber: Larson's group noted that US intakes run at roughly half of recommended levels, and acacia is one of many ways to close part of that gap.

Bottom line

Low fiber intake shows up as infrequent, hard stools, not as a lack of any particular gum.

Toxicity Symptoms

At high intake

Gum arabic has a clean toxicology file. EFSA's 2017 panel found no adverse effects in subchronic and carcinogenicity studies at the highest doses tested, no genotoxicity concern, and good tolerance of 30 g a day (about 430 mg/kg body weight) for up to 18 days. A 103-week US National Toxicology Program feeding study in rats and mice at up to 5 percent of the diet found no carcinogenicity (as reviewed by EFSA in 2017). EFSA's 2019 follow-up on infants under 16 weeks received no clinical data from industry but found large safety margins from the animal studies, while recommending lower limits for toxic elements, a new aluminum specification, microbiological criteria and inactivation of the gum's natural oxidizing enzymes. The human ceiling is gut comfort: at 40 g in one sitting, bloating and flatulence rise. The highest sustained intakes found, 50 g a day for 3 months in dialysis patients, came with a measurable rise in serum calcium.

Signs to reduce or stop

• Bloating, cramping or diarrhea that persists past the first week, or that returns at each dose increase

• Wheeze, cough, runny nose or hives when handling the powder, or itching of the mouth after taking it; swelling of the lips, face or throat, or trouble breathing, after taking it needs emergency care

• In kidney disease: a change in potassium, calcium or sodium on routine blood tests after starting it

• An infection that is not responding to amoxicillin taken alongside the fiber

General note

The hazards of gum arabic are allergy in sensitized people, mineral load in failing kidneys, and the chance that it is used in place of real treatment. Toxicity in the ordinary sense has not been found.

How Gum Arabic Works

Every effect of gum arabic starts in the gut, because the gum is not absorbed intact.

A soluble fiber that does not thicken

The arabinogalactan core is compact and highly branched; neutron scattering shows the main fraction as a thin disk about 20 nm across and under 2 nm thick (Sanchez and colleagues, Biophysical Journal 2007). That shape lets the gum dissolve at very high concentration without becoming viscous, which is why it works as an emulsifier in a soft drink.

Slow fermentation in the colon

EFSA describes acacia gum as "slightly fermented" by intestinal bacteria. Ross's 1983 study could not recover the gum from stool, and breath hydrogen, a marker of colonic fermentation, rose only after chronic administration, which suggests the colonic bacteria take time to adapt. The Wageningen authors cite a laboratory gut model showing fermentation continuing into the distal colon, which they offer as a likely reason for its good tolerance. The products of that fermentation are short-chain fatty acids, which EFSA judged of no safety concern. Calame's increase in bifidobacteria and lactobacilli at 10 g is the measured microbial consequence.

Bowel frequency

The proposed route is more bacterial mass and therefore more stool, which Bliss measured in kidney patients on 50 g a day. The Wageningen authors also mention unpublished in-house data linking acacia to intestinal serotonin; those data were not shown.

Glucose

In mice, gum arabic reduced expression of the intestinal sodium-coupled glucose carrier SGLT1 and delayed glucose absorption (reviewed by Nasir, Kidney and Blood Pressure Research 2013). Whether that happens in people at supplement doses is untested; in the Minnesota trial the human effect was a small, inconsistent dip at 30 minutes.

Minerals

Mice drinking 10 percent gum arabic solution for up to 14 days absorbed and excreted more calcium and magnesium, showed higher creatinine clearance and had lower plasma levels of active vitamin D (1,25-dihydroxyvitamin D) (Nasir and colleagues, Journal of Renal Nutrition 2008), at a dose far above any human intake.

What is not known

Which fraction (arabinogalactan, arabinogalactan-protein or glycoprotein) carries each effect; whether A. senegal and A. seyal gums ferment differently in people; and whether blood butyrate rises in humans at 10 g a day.

Synergistic Supplements

No combination involving gum arabic has been tested against its parts in a trial built to show synergy.

• Probiotics. Wageningen tested acacia fiber and Bifidobacterium animalis BLa80 in separate arms. The probiotic reduced IBS symptom severity; the fiber increased stool frequency. The authors suggested a combined arm for future work; none was run.

• Inulin. In Calame's trial, 10 g of gum arabic raised bifidobacteria more than 10 g of inulin. The two were not combined.

• Other fibers. The Wageningen authors placed acacia's 1.3 extra stools a week beside meta-analysis figures of about 1.0 for inulin or galacto-oligosaccharides and 0.9 for psyllium, which has its own issue in this archive. Those are cross-trial comparisons, not head-to-head results. Stacking several fiber powders at full dose mainly stacks the gas.

Interactions & What NOT to Take

Amoxicillin

Eltayeb and colleagues studied the effect of gum arabic on a single oral dose of amoxicillin in healthy Sudanese volunteers (Journal of Antimicrobial Chemotherapy 2004;54:577), and drug-interaction references summarize the finding as reduced amoxicillin absorption. The full letter, with its participant numbers, doses and stated rationale, could not be accessed for this issue. It matters most where gum arabic is taken daily alongside prescribed medicines, as in its folk use for kidney failure in Sudan. Take the antibiotic at a different time of day and tell the prescriber about the fiber.

Glucose-lowering drugs

No interaction study was found for metformin, sulfonylureas or insulin, or for any other named drug besides amoxicillin. Diabetic participants in the Khartoum trial were on hypoglycemic agents while taking 30 g a day, and the 2026 meta-analysis found lower fasting glucose, so additive lowering is possible in principle. Monitor more closely when starting.

What NOT to take

• Any "acacia" weight-loss or energy product listing Acacia rigidula, in place of or alongside acacia fiber

• Full doses of acacia on top of several other fiber supplements at once

• Gum arabic as a substitute for dialysis, kidney diet prescriptions or diabetes medication

Quality, Testing & Adulteration

The other acacia: an amphetamine isomer in weight-loss products

FDA chemists led by Rahul Pawar analyzed 21 supplements labeled as containing Acacia rigidula (Journal of Pharmaceutical and Biomedical Analysis 2013). Two samples of authenticated leaf contained six biogenic amines totaling 18.6 and 32.9 µg/g. Nine of the 21 products contained β-methylphenethylamine (BMPEA), a synthetic positional isomer of amphetamine not found in the plant, at 960 to 60,500 µg/g. Cohen and colleagues bought 21 brands more than a year later and found BMPEA in 11 (Drug Testing and Analysis 2015), at amounts that would deliver up to 93.7 mg a day at maximum label servings. On April 23, 2015 FDA sent warning letters to five companies covering eight products, stating that BMPEA does not meet the definition of a dietary ingredient. A 2015 case report described a hemorrhagic stroke probably caused by exercise combined with a sports supplement containing BMPEA (Cohen and colleagues, Annals of Internal Medicine). None of this involves gum arabic, but a search for "acacia" can land a buyer on these products.

Species and grade substitution

Cheaper A. seyal gum, and gums from other trees, can be blended into A. senegal gum. Vanloot and colleagues at Aix-Marseille University showed that mid-infrared spectroscopy separates the two acacia species without ambiguity, distinguishes them from Combretum, ghatti, karaya and tragacanth gums, and detects adulteration at 3.4 percent (Food Chemistry 2012). JECFA's optical rotation, iodine and ferric chloride tests are the cheaper screens.

Origin laundering

A report by the Dutch peace organization PAX, as described by Al Jazeera in January 2026, found that most Sudanese gum is now smuggled, mainly into Chad and South Sudan, and sometimes mixed with local gum and relabeled with another country of origin. The UN human rights office reported in July 2026, citing UN Security Council experts, that at least 3,700 tonnes were looted between January and June 2024, and traced routes through Douala, Cameroon, where gum is relabeled. Nexira told Al Jazeera it had suspended purchases where it could not maintain visibility; Alland & Robert said it can trace every batch. A Chadian or Cameroonian origin on the paperwork is therefore not proof of conflict-free sourcing.

What third-party marks cover

None of the three retail labels reviewed here carried a USP or NSF verification mark. NOW and Swanson carry organic certification, which covers farming and handling, not fiber content, species or heavy metals; Fair for Life, held by specific Nexira grades, covers trading conditions.

What a lab report on acacia ought to list

Species, with the optical rotation result; soluble fiber as a percentage of dry weight; loss on drying (10 percent maximum for spray-dried gum); total ash against JECFA's 4 percent; lead against JECFA's 2 mg/kg; Salmonella and E. coli absent; total aerobic count and yeasts and molds, which EFSA asked to be added to EU specifications in 2017; aluminum, flagged by EFSA in 2017 and 2019; and country of harvest with a named chain of custody.

Checks a buyer can run

• Divide grams of fiber by grams of powder per serving. NOW's 6 g in 6.5 g is 92 percent; a much lower ratio is worth a question to the brand.

• Read the species line. "Acacia senegal" alone, or "senegal and seyal," tells you which species you are buying.

• If the front says "acacia" and the back lists caffeine, phenethylamine or Acacia rigidula, it is a stimulant, not a fiber.

• Dissolve a teaspoon in water. Gum arabic gives a thin liquid, not a gel.

Special Considerations

Doses used in trials (research history, not instructions)

Single meals of 20 g (Sharma) and 20 or 40 g (Larson 2021); 30 g a day for 6 weeks (Babiker 2012), for 3 months in type 2 diabetes (Babiker 2018) and for 12 weeks in sickle cell anemia from age 5 (Kaddam 2015); 50 g a day in kidney failure (Bliss 1996; Ali 2008, 3 months); 10 to 40 g a day for 4 weeks in kidney disease (Elamin 2017). Every kidney and sickle cell regimen was given under medical supervision. None of these is an amount for a person with kidney disease to take on their own.

Infants

EFSA's 2019 opinion assessed E 414 only as carry-over in infant formula and found large margins of safety, with no clinical data submitted. That is not a basis for giving fiber powder to a baby.

Workers

Candy makers, tablet coaters and anyone pouring the powder in bulk carry the documented allergy risk. Respiratory symptoms at work deserve an occupational medicine referral.

Sourcing

A jar of acacia fiber connects the buyer to a supply chain the UN says is linked to looting and abuses in Sudan. Asking a brand for country of harvest and chain of custody is a legitimate quality question.

Research Status & Evidence Quality

Tier 1, regulatory assessments: FDA's 2021 fiber decision; EFSA 2017 and 2019; JECFA (ADI not specified, 1989).

Tier 2, randomized trials: IBS with constipation (Wageningen, 180 randomized); bifidobacteria (Calame, 48 completers in six arms); acute glucose and satiety (Minnesota crossover, 48); body composition and diabetes (Babiker, 120 and 91); kidney disease (Bliss 16, Ali 36, Elamin 30 completers); a 2026 meta-analysis of 6 trials (476 participants).

Tier 3, uncontrolled studies and case reports: sickle cell (47, no control group); the Baghdad dialysis-avoidance series (6); occupational allergy reports from the 1950s onward; oral allergy case reports (1993, 2011).

Tier 4, animal work: mouse studies of minerals, kidney function and glucose transport.

Research Limitations

• Most efficacy trials used 20 to 50 g a day, far above label servings.

• Several key trials were funded by, or used product supplied by, gum suppliers, and one petition study was unpublished.

• No trial found for this issue ran longer than 3 months or measured clinical events.

• Species and grade are often unstated in the methods.

Summary & Key Takeaways

Bottom Line

Gum arabic is a well-tolerated soluble fiber with a clean safety file and a narrow evidence base. At 10 g a day it raised stool frequency in IBS with constipation by 1.3 bowel movements a week, 0.9 more than placebo, and shifted gut bacteria toward bifidobacteria. Its US fiber status rests on an acute blood sugar effect that the University of Minnesota trial could not confirm on glucose area under the curve. Most other benefits come from small Sudanese trials at 30 to 50 g a day.

Key Safety Points

• Gum arabic dust causes occupational asthma; sensitized workers should avoid it. Allergy from eating it is rare but has included anaphylaxis.

• It does not replace dialysis; in the published case series of that approach, two of the three patients given the gum died, and the claim rests on one survivor.

• People with kidney disease should ask before using a powder that is a calcium, magnesium and potassium salt.

• Separate it from amoxicillin.

• "Acacia" stimulant products containing Acacia rigidula are a different, hazardous category.

Special Note

The industry's first fiber petition failed in January 2020. The second succeeded in December 2021 by narrowing the claim to blood sugar. The tablespoon on the jar is about a third to a sixth of the doses behind that claim.

Forwarded this, or reading it on the web? to get the next breakdown.

Researched and drafted with AI assistance. Every claim verified against primary sources and human-reviewed before publication. Last reviewed: November 2, 2026. Corrections: reply to any issue.

This issue is for education only and is not medical advice. If you take medication, have kidney disease or diabetes, or are pregnant, talk with a clinician before adding gum arabic or any fiber supplement.